Ted Lee

No ORCID on file · 38 papers in corpus · active 2010-2026

Study types

  • preprint 23
  • article 9
  • book-chapter 2
  • supplementary-materials 2
  • other 1

Condition tags

  • endometriosis 36
  • mesh:D004715 6
  • bowel_endometriosis 2
  • infertility 2
  • mesh:D017699 1
  • dyspareunia 1
book-chapter 2026
·doi:10.1201/9781003312109-24

Endometriosis is the presence of endometrium-like tissue outside the uterus and can take many forms that include superficial peritoneal lesions, cysts in the ovaries known as endometriomas, and deep endometriosis penetrating at least 5 mm i…

article 2025
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2025.09.525

Endometriosis is a chronic disease that is characterized by pain, infertility, and reduced quality of life. Despite varied treatment modalities, a high proportion of individuals experience debilitating symptoms and develop comorbid pain con…

article 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.01.021

Given the complexities and controversies that exist in diagnosing adult endometriosis, as well as optimizing medical and surgical management, it is not surprising that there is even more ambiguity and inconsistency in the optimal surgical c…

preprint 2023
·doi:10.1158/1078-0432.c.6522953

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

preprint 2023
·doi:10.1158/1078-0432.c.6522953.v1

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

preprint 2023
·doi:10.1158/1078-0432.c.6521559

AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…

preprint 2023
·doi:10.1158/1078-0432.c.6521559.v1

AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…

preprint 2023
·doi:10.1158/1078-0432.22449093.v1

PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…

preprint 2023
·doi:10.1158/1078-0432.22449093

PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…

preprint 2023
·doi:10.1158/1078-0432.22455170

Supplementary Materials and Methods

preprint 2023
·doi:10.1158/1078-0432.22455170.v1

Supplementary Materials and Methods

supplementary-materials 2023
·doi:10.1158/1078-0432.22449087

PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…

supplementary-materials 2023
·doi:10.1158/1078-0432.22449087.v1

PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…

preprint 2023
·doi:10.1158/1078-0432.22455191

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

preprint 2023
·doi:10.1158/1078-0432.22455191.v1

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

preprint 2023
·doi:10.1158/1078-0432.22455188

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

preprint 2023
·doi:10.1158/1078-0432.22455188.v1

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

preprint 2023
·doi:10.1158/1078-0432.22455185.v1

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity

preprint 2023
·doi:10.1158/1078-0432.22455185

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity

preprint 2023
·doi:10.1158/1078-0432.22455182

Suppl Fig S4. Complement and non-target siRNA

preprint 2023
·doi:10.1158/1078-0432.22455182.v1

Suppl Fig S4. Complement and non-target siRNA

preprint 2023
·doi:10.1158/1078-0432.22455179.v1

Suppl Table S1. Differentially expressed genes from different group comparisons

preprint 2023
·doi:10.1158/1078-0432.22455179

Suppl Table S1. Differentially expressed genes from different group comparisons

preprint 2023
·doi:10.1158/1078-0432.22455176.v1

Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses

preprint 2023
·doi:10.1158/1078-0432.22455176

Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses